RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KPRX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Tuesday for Kiora Pharmaceuticals, Inc.
(Updated on Jul 02, 2024)

Buy or Hold candidate since Jun 12, 2024 Loss -9.76% PDF

The Kiora Pharmaceuticals, Inc. stock price gained 2.07% on the last trading day (Tuesday, 2nd Jul 2024), rising from $4.35 to $4.44. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.21% from a day low at $4.27 to a day high of $4.54. The price has risen in 7 of the last 10 days and is up by 4.96% over the past 2 weeks. Volume fell on the last day by -60 thousand shares and in total, 12 thousand shares were bought and sold for approximately $51.15 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 195.82% during the next 3 months and, with a 90% probability hold a price between $4.24 and $17.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KPRX Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Friday, June 14, 2024, and so far it has fallen -17.16%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. The Kiora Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.20 and $2.16. A breakdown below any of these levels will issue sell signals. The stock had a Golden Star Signal on Monday, October 30, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Monday, October 30, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Kiora Pharmaceuticals, Inc. stock

Kiora Pharmaceuticals, Inc. finds support from accumulated volume at $4.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.265 between high and low, or 6.21%. For the last week the stock has had daily average volatility of 10.41%.

Our recommended stop-loss: $4.24 (-4.61%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (KPRX) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Kiora Pharmaceuticals, Inc. to open at $4.42, and during the day (based on 14 day Average True Range), to move between $3.98 and $4.90, which gives a possible trading interval of +/-$0.456 (+/-10.28%) up or down from last closing price. If Kiora Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 20.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.35 (2.03%) than the resistance at $4.84 (9.01%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kiora Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Kiora Pharmaceuticals, Inc. stock to perform well in the short-term.

Current score: 2.483 Buy Candidate Unchanged

Predicted Opening Price for Kiora Pharmaceuticals, Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$4.42 ( 0.563%) $4.44

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KPRX

Fibonacci Support & Resistance Levels

Level Price
R3 4.68 5.41%
R2 4.58 3.13%
R1 4.52 1.72%
Price 4.44
S1 4.31 -2.84%
S2 4.25 -4.25%
S3 4.15 -6.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.36 20.72%
R2 4.92 10.81%
R1 4.84 9.01%
Price 4.44
S1 4.35 -2.03%
S2 4.23 -4.73%
S3 4.00 -9.91%

FAQ

What is the symbol for Kiora Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Kiora Pharmaceuticals, Inc. is KPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Kiora Pharmaceuticals, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Kiora Pharmaceuticals, Inc. stock to perform well in the short-term.

How to buy Kiora Pharmaceuticals, Inc. Stock?
Kiora Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Kiora Pharmaceuticals, Inc. Stock.

What's the current price of Kiora Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an Kiora Pharmaceuticals, Inc. (KPRX) share was $4.44.

What is the 52-week high and low for Kiora Pharmaceuticals, Inc. Stock?
The 52-week high for Kiora Pharmaceuticals, Inc. Stock is $5.55 and the 52-week low is $0.400.

What is the market capitalization of Kiora Pharmaceuticals, Inc. Stock?
As of the Jul 02, 2024, the market capitalization of Kiora Pharmaceuticals, Inc. is 12.922M.

When is the next earnings date for Kiora Pharmaceuticals, Inc.?
The upcoming earnings date for Kiora Pharmaceuticals, Inc. is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals. Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, a... KPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT